Comprehensive RNA involved in Cell Death Pathways research database with advanced search and filtering capabilities
| RNA Name | Mechanism of Action | Effect on Cancer | Reference |
|---|---|---|---|
|
8 differentially expressed lncRNAs (AL928768.3,CTA.384D8.35,CTB.33O18.1,CTB.33O18.2,LINC00519,LINC00987,PTPRD.AS1,RP11.1070N10.3, RP5.1028K7.2
lncRNA |
Linked to pyroptosis and breast cancer lung metastasis | Correlates with survival, immune responses, and PD-1 therapy response | PMID: 35309942 |
External Database SearchDetailed Information
RNA Name:
8 differentially expressed lncRNAs (AL928768.3,CTA.384D8.35,CTB.33O18.1,CTB.33O18.2,LINC00519,LINC00987,PTPRD.AS1,RP11.1070N10.3, RP5.1028K7.2
Mechanism of Action:
Linked to pyroptosis and breast cancer lung metastasis
Effect on Cancer:
Correlates with survival, immune responses, and PD-1 therapy response
PMID:
35309942
|
|||
|
9-pyroptosis-associated lncRNAs AL928768.3, CTA.384D8.35, CTB.33O18.1, CTB.33O18.2, LINC00519, LINC00987, PTPRD.AS1, RP11.1070N10.3, RP5.1028K7.2
lncRNA |
Associated with immune microenvironment and prognosis | High predictive power for survival and therapeutic response | PMID: 34616734 |
External Database SearchDetailed Information
RNA Name:
9-pyroptosis-associated lncRNAs AL928768.3, CTA.384D8.35, CTB.33O18.1, CTB.33O18.2, LINC00519, LINC00987, PTPRD.AS1, RP11.1070N10.3, RP5.1028K7.2
Mechanism of Action:
Associated with immune microenvironment and prognosis
Effect on Cancer:
High predictive power for survival and therapeutic response
PMID:
34616734
|
|||
|
8 differentially expressed lncRNAs 0.0, AC004585.1, DLGAP1-AS1, TNFRSF14-AS1, AL606834.2, Z68871.1, AC009119.1, LINC01871, AL136368.1
lncRNA |
Integrated risk model with immune infiltration and signaling analysis | Prognostic significance and therapeutic implications | PMID: 34632690 |
External Database SearchDetailed Information
RNA Name:
8 differentially expressed lncRNAs 0.0, AC004585.1, DLGAP1-AS1, TNFRSF14-AS1, AL606834.2, Z68871.1, AC009119.1, LINC01871, AL136368.1
Mechanism of Action:
Integrated risk model with immune infiltration and signaling analysis
Effect on Cancer:
Prognostic significance and therapeutic implications
PMID:
34632690
|
|||
|
7 pyroptosis-related lncRNAs AC005034.5, AC027307.2,AC121761.2,AL451085.2, AL513477.2,LINC01871,U73166.1
lncRNA |
Risk model linked to angiogenesis, TGF-β, and immune cell infiltration | Potential biomarkers and therapeutic targets | PMID: 34552353 |
External Database SearchDetailed Information
RNA Name:
7 pyroptosis-related lncRNAs AC005034.5, AC027307.2,AC121761.2,AL451085.2, AL513477.2,LINC01871,U73166.1
Mechanism of Action:
Risk model linked to angiogenesis, TGF-β, and immune cell infiltration
Effect on Cancer:
Potential biomarkers and therapeutic targets
PMID:
34552353
|
|||
|
miR-204-5p
miRNA |
Regulates the SLC31A1 expression, part of the LINC01614/miR-204-5p/SLC31A1 axis | Associated with immune infiltration and poor prognosis | PMID: 37884650 |
External Database SearchDetailed Information
RNA Name:
miR-204-5p
Mechanism of Action:
Regulates the SLC31A1 expression, part of the LINC01614/miR-204-5p/SLC31A1 axis
Effect on Cancer:
Associated with immune infiltration and poor prognosis
PMID:
37884650
|
|||
|
miR-200c-3p
miRNA |
Regulates ZFPM2 and CFL2 | Associated with TNBC prognosis and immune infiltration | PMID: 38601669 |
External Database SearchDetailed Information
RNA Name:
miR-200c-3p
Mechanism of Action:
Regulates ZFPM2 and CFL2
Effect on Cancer:
Associated with TNBC prognosis and immune infiltration
PMID:
38601669
|
|||
|
miR-203a-3p
miRNA |
Target of cuproptosis-related genes (CRGs) | Potential therapeutic target for TNBC | PMID: 38601669 |
External Database SearchDetailed Information
RNA Name:
miR-203a-3p
Mechanism of Action:
Target of cuproptosis-related genes (CRGs)
Effect on Cancer:
Potential therapeutic target for TNBC
PMID:
38601669
|
|||
|
miR-370-3p
miRNA |
Targets DLD mRNA | Associated with endocrine therapy resistance in ER+ breast cancer | PMID: 37143115 |
External Database SearchDetailed Information
RNA Name:
miR-370-3p
Mechanism of Action:
Targets DLD mRNA
Effect on Cancer:
Associated with endocrine therapy resistance in ER+ breast cancer
PMID:
37143115
|
|||
|
miR-432-5p
miRNA |
Targets DLD mRNA | Associated with endocrine therapy resistance in ER+ breast cancer | PMID: 37143115 |
External Database SearchDetailed Information
RNA Name:
miR-432-5p
Mechanism of Action:
Targets DLD mRNA
Effect on Cancer:
Associated with endocrine therapy resistance in ER+ breast cancer
PMID:
37143115
|
|||
|
miR-192-5p
miRNA |
Part of the PRNP/miRNA hsa-miR-192-5p and hsa-miR-215-5p/lncRNA CARMN ceRNA network | Implicated in cuproptosis regulation | PMID: 36980514 |
External Database SearchDetailed Information
RNA Name:
miR-192-5p
Mechanism of Action:
Part of the PRNP/miRNA hsa-miR-192-5p and hsa-miR-215-5p/lncRNA CARMN ceRNA network
Effect on Cancer:
Implicated in cuproptosis regulation
PMID:
36980514
|
|||